This episode of the Rapid Risk Review Podcast delves into GLP-1 agonists, a class of medications that have gained popularity for diabetes and weight management. The discussion covers the risks associated with prescribing these medications, including on-label and off-label uses, the role of compounding pharmacies, and the importance of shared decision-making between healthcare providers and patients. Experts highlight the challenges posed by medication shortages and the potential dangers of compounded drugs, emphasizing the need for thorough patient education and careful selection of pharmacies.